NEWS BRIEF · Research journal
Rare GLP1R variants attenuate weight loss with semaglutide but not tirzepatide
From the report
Nature Metabolism, Published online: 11 November 2026; doi:10.1038/s42255-026-01656-zRare GLP1R variants are shown to reduce weight loss with semaglutide but not tirzepatide, suggesting GLP1R genetic variation as a pharmacogenetic determinant of GLP-1 receptor agonist efficacy.

